EUVIMEDEUVIMED entdecken
Crossref

Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles

Kamaldeep, Sarvesh Loharkar, Tapas Das, Sandip Basu iD, Sharmila Banerjee iD

Cancer Biotherapy and Radiopharmaceuticals · 01.04.2022 · 37 (3) · 214-225

DOI: 10.1089/cbr.2021.0340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, erschienen am 01.04.2022. Verfasst von Kamaldeep und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsOrganometallic CompoundsHeterocyclic Compounds, 1-RingHumansLutetiumOctreotideProspective StudiesRadioisotopes

Stichwörter der Autor:innen

OLINDAPRRT[177Lu]Lu-DOTA-TATEdosimetryneuroendocrine tumorsscintigraphy

Substanzen

Heterocyclic Compounds, 1-RingOrganometallic CompoundsRadioisotopes1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidLutetiumLutetium-177Octreotide

Autor:innen und Institutionen

  • Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.
  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.

ORCID-Profile: Sandip Basu, Sharmila Banerjee

Zitieren

APA

Kamaldeep, Loharkar, S., Das, T., Basu, S., & Banerjee, S. (2022). Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles. Cancer Biotherapy and Radiopharmaceuticals, 37(3), 214-225. https://doi.org/10.1089/cbr.2021.0340

Vancouver

Kamaldeep, Loharkar S, Das T, Basu S, Banerjee S. Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(3):214-225. doi:10.1089/cbr.2021.0340

BibTeX
@article{Kamaldeep2022,
  author = {Kamaldeep and Loharkar, Sarvesh and Das, Tapas and Basu, Sandip and Banerjee, Sharmila},
  title = {Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2022},
  volume = {37},
  number = {3},
  pages = {214--225},
  doi = {10.1089/cbr.2021.0340}
}
Kostenlos starten →